These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34624565)

  • 1. Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells.
    Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
    Tissue Cell; 2021 Dec; 73():101655. PubMed ID: 34624565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
    Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
    Deng H; Gong X; Ji G; Li C; Cheng S
    Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway.
    Ma S; Wang Q; Ma X; Wu L; Guo F; Ji H; Liu F; Zhao Y; Qin G
    Tumour Biol; 2016 Jan; 37(1):989-98. PubMed ID: 26264613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway.
    Zhao JJ; Hao S; Wang LL; Hu CY; Zhang S; Guo LJ; Zhang G; Gao B; Jiang Y; Tian WG; Luo DL
    Oncotarget; 2016 Sep; 7(36):57903-57918. PubMed ID: 27507052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7a Inhibits Tumor Metastasis by Regulating TGF-β/Smad Signaling in the Colorectal Adenocarcinoma Cell Line LS-174T.
    Cao W; Wang Q; Huang C
    Anticancer Res; 2021 Aug; 41(8):3801-3808. PubMed ID: 34281839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
    Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
    J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck.
    Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X
    Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathway.
    Xiao J; Xiang Q; Xiao YC; Su ZJ; Huang ZF; Zhang QH; Tan Y; Li XK; Huang YD
    J Exp Clin Cancer Res; 2010 Apr; 29(1):35. PubMed ID: 20416076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Rap1GAP Expression Activates the TGF-
    Yan Z; Yangyanqiu W; Shuwen H; Jing M; Haihong L; Gong C; Yin J; Qing Z; Weili G
    Biomed Res Int; 2021; 2021():6840642. PubMed ID: 34840979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.
    Lee YJ; Park JH; Oh SM
    Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wulong Xiaozheng Wan medicated serum inhibits epithelial-mesenchymal transition in human gastric carcinoma cell line BGC823 by modulation of transforming growth factor-β1/Smad signaling.
    Zhang Y; Wang B; Yang L; Li D; Yuan X; Guo X
    J Tradit Chin Med; 2019 Jun; 39(3):380-392. PubMed ID: 32186010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
    Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
    PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
    Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
    Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer.
    You X; Wu J; Zhao X; Jiang X; Tao W; Chen Z; Huang C; Zheng T; Shen X
    Aging (Albany NY); 2021 Jul; 13(14):18464-18481. PubMed ID: 34260413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.